HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA-B57 is significantly associated with psoriasis in Northeast Romania [corrected].

AbstractUNLABELLED:
The aim of the study was to identify HLA class I types associated with susceptibility to psoriasis among population of Northeast region of Romania.
PATIENTS AND METHODS:
27 psoriatic patients and 89 controls were typed serologically for HLA-A and HLA-B lymphocyte expression using CDC-NIH (complement dependent-cytotoxicity--National Institute of Health) method. The Terasaki plates used for HLA class I typing were prepared in our laboratory using antisera of known specificities.
RESULTS AND CONCLUSIONS:
psoriatic patients in the group of study frequently express HLA-B57 phenotype. The relative risk induced by this phenotype was highly statistically significant (p = 0.0016) while HLA-B13 was not associated with a significant risk for developing psoriasis in patients under study compared with controls (p = 0.48). Also, HLA-B27 (p = 0.96) and HLA-B44 (p = 0.99), reported by others to be associated with late psoriasis, do not meet (a particular) disease susceptibility between psoriatic patients under investigation.
AuthorsVenera Vasilca, A Vasilca, Dorina Munteanu, Daniela Constantinescu, Cristina Livideanu, Maria Tepeluş, F Zugun, E Carasevici
JournalRoumanian archives of microbiology and immunology (Roum Arch Microbiol Immunol) 2002 Oct-Dec Vol. 61 Issue 4 Pg. 259-65 ISSN: 1222-3891 [Print] Romania
PMID15055259 (Publication Type: Journal Article)
Chemical References
  • HLA-B Antigens
  • HLA-B57 antigen
Topics
  • Adult
  • Female
  • Genetic Predisposition to Disease (genetics)
  • HLA-B Antigens (genetics)
  • Histocompatibility Testing
  • Humans
  • Male
  • Middle Aged
  • Psoriasis (genetics)
  • Romania

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: